Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 346.71M | 307.02M | 315.55M | 369.56M | 357.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 346.71M | 307.02M | 315.55M | 369.56M | 357.00M |
| Cost of Revenue | 43.21M | 39.52M | 44.00M | 35.84M | 40.77M |
| Gross Profit | 303.50M | 267.51M | 271.54M | 333.72M | 316.23M |
| SG&A Expenses | 161.80M | 164.24M | 158.47M | 160.04M | 164.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 274.08M | 271.22M | 268.45M | 257.59M | 271.90M |
| Operating Income | 72.63M | 35.81M | 47.09M | 111.97M | 85.10M |
| Income Before Tax | 71.60M | 41.67M | 55.52M | 120.25M | 86.05M |
| Income Tax Expenses | 17.92M | -7.99M | 8.97M | 28.02M | 17.98M |
| Earnings from Continuing Operations | 53.68M | 49.65M | 46.54M | 92.23M | 68.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -354.00K | -322.00K | -471.00K | -433.00K | -248.00K |
| Net Income | 53.33M | 49.33M | 46.07M | 91.79M | 67.82M |
| EBIT | 72.63M | 35.81M | 47.09M | 111.97M | 85.10M |
| EBITDA | 96.77M | 57.80M | 69.02M | 133.51M | 107.46M |
| EPS Basic | 0.56 | 0.52 | 0.48 | 0.95 | 0.71 |
| Normalized Basic EPS | 0.53 | 0.31 | 0.35 | 0.80 | 0.59 |
| EPS Diluted | 0.55 | 0.51 | 0.48 | 0.94 | 0.70 |
| Normalized Diluted EPS | 0.53 | 0.31 | 0.35 | 0.79 | 0.58 |
| Average Basic Shares Outstanding | 95.47M | 95.63M | 95.90M | 96.33M | 95.62M |
| Average Diluted Shares Outstanding | 96.52M | 96.85M | 96.90M | 97.47M | 97.15M |
| Dividend Per Share | 0.36 | 0.36 | 0.33 | 0.33 | 0.33 |
| Payout Ratio | 64.39% | 64.03% | 68.66% | 34.67% | 46.52% |